Loading…
Held by equity mutual funds in 91 disclosed months, Sep 2012 to Sep 2026.
Hikal Limited (Pharmaceuticals & Biotechnology) was held by 1 active equity mutual fund in September 2026, ₹64.9 Cr in all (down 1 fund from Aug 2026). The largest position was ICICI Prudential Healthcare Fund at 0.9% of its portfolio. During the month 0 funds entered and 1 exited. Funds have disclosed holding it since Sep 2012.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
None.
How many equity funds held the company each month, and the value they held.